Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection

[1]  Amit G. Singal,et al.  Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis , 2014, PLoS medicine.

[2]  Hideo Tanaka,et al.  Burden of Total and Cause-Specific Mortality Related to Tobacco Smoking among Adults Aged ≥45 Years in Asia: A Pooled Analysis of 21 Cohorts , 2014, PLoS medicine.

[3]  S. Chaouir,et al.  Intracranial Cryptococcal Infection in HIV Positive Patient , 2014 .

[4]  F. Zanconati,et al.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. , 2014, World journal of gastroenterology.

[5]  J. Trojan,et al.  Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. , 2013, European journal of cancer.

[6]  Hassan Khaled Hamdy,et al.  Impact of hepatocellular carcinoma on health related quality of life in Egyptian patients: a single centre study. , 2013, Journal of the Egyptian Society of Parasitology.

[7]  S. Ceccarelli,et al.  Dual Role of MicroRNAs in NAFLD , 2013, International journal of molecular sciences.

[8]  Yi-yao Xu,et al.  The role and clinical implications of microRNAs in hepatocellular carcinoma , 2012, Science China Life Sciences.

[9]  Pavlina Konstantinova,et al.  Adenosine triphosphate‐binding cassette transporter genes up‐regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs , 2012, Hepatology.

[10]  M. Albitar,et al.  Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.

[11]  W. Tan,et al.  Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis , 2011, Molecular Carcinogenesis.

[12]  G. Gerken,et al.  Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion , 2010, Molecular Cancer.

[13]  G. Illei,et al.  MicroRNAs as biomarkers in rheumatic diseases , 2010, Nature Reviews Rheumatology.

[14]  Robert Valentine,et al.  Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation , 2010, Molecular Cancer.

[15]  K. Horimoto,et al.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.

[16]  J. Friedman,et al.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. , 2009, Biochemical and biophysical research communications.

[17]  William A Robinson,et al.  Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.

[18]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[19]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[20]  Peter Schirmacher,et al.  MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.

[21]  J. Bruix,et al.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.

[22]  C. Croce,et al.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.

[23]  L. Lim,et al.  Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression , 2007, Molecular and Cellular Biology.

[24]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  Chen-Yu Zhang,et al.  Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. , 2014, Clinical laboratory.

[27]  Z. Siddiqui,et al.  The Significance of Circulating Micro RNA-122 as a Non Invasive Diagnostic Marker of Liver Injury in Egyptian Chronic Hepatitis C virus Infected and Cirrhotic Patients with and without Hepatocellular Carcinoma , 2014 .

[28]  H. Katayama,et al.  Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. , 2013, Neoplasma.